ARCHIVES

Revlimid Also Demonstrates Response in Mantle Cell

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

NCI Gets Out of the News Business

January 25, 2013